611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
AHA News: Women May Be More Willing Than Men to Donate OrgansDNA Sensor Can Spot When COVID Is ContagiousTrials Show COVID Vaccines Well Worth It for Cancer PatientsCDC Endorses Booster Shots for Millions of AmericansChildhood Trauma Linked With Higher Odds for Adult Neurological IllsStudy Probes Relationship Between Migraines and SleepCancer in Hispanics: Good News and BadFDA Approves Pfizer Booster Shots for Seniors, High-Risk AmericansU.S. to Buy 500 Million More COVID Vaccine Doses for Global DonationAntibodies to Early Strains of COVID May Not Fight New Variants: StudyPregnant Women Who Get COVID Vaccine Pass Antibodies to NewbornsCDC Expert Panel to Weigh In on Vaccine BoostersWhich Kids Are at Highest Risk From COVID?4 Out of 10 Adults With No Known Heart Disease Have Fatty Hearts: StudyBooster Dose of J&J COVID Vaccine Increases ImmunityPost-Stroke Rehab: There's a Sweet Spot in the TimingCommon Form of Liver Cancer on the Rise in Rural AmericaCOVID Has Killed More Americans Than the Spanish Flu Did in 1918Telemedicine Gets High Marks for Follow-Ups After SurgeryPandemic Tied to Declining Birth Rates for U.S., Much of EuropeStudy Spots People at High Risk of Severe Breakthrough COVIDReview of Booster Shots for Moderna, J&J Vaccines Just Weeks Away: FauciDelta Variant Now Fueling 99% of U.S. COVID CasesLower Dose of Pfizer COVID Vaccine Works Well in Young Children, Company SaysFDA Panel OKs Pfizer Booster Shot for  People 65 or Older, But Not YoungerLong-Haul COVID in Kids Typically Ends Within 3 Months: StudyPfizer, Moderna Vaccines Still Offer Good Protection Against Severe COVID: StudyTrial Into Antioxidant for Parkinson's Disease Yields Disappointing ResultsIs Flu Ready for a Comeback? Get Your ShotCommon Eye Conditions Tied to Higher Risk for DementiaDrug Might Stop Heart Trouble Linked to Sickle Cell AnemiaChild Obesity Rose Sharply During PandemicFDA Advisory Panel to Meet on COVID Booster ShotsStatin Cholesterol Drugs May Help Fight Ulcerative ColitisAHA News: Physical Activity Is Helpful After a Stroke, But How Much Is Healthy?Special 'Strategies' Can Help People With Parkinson's Walk, But Many Patients UnawareEven When Undergoing Treatment, People With MS Gain From COVID VaccinesNIH Spending Nearly $470 Million on Long-Haul COVID StudyHospitalizing the Unvaccinated Has Cost U.S. Nearly $6 BillionIn 16 States, 35% or More Residents Now Obese: CDCPet Store Puppies Passing Drug-Resistant Bacteria to PeopleIs a Combo COVID/Flu Shot on the Way?1 in 500 Americans Has Died From COVID-19Having Even a Cousin or Grandparent With Colon Cancer Raises Your Risk: StudyBlood Cancer Patients Could Benefit From COVID Booster Shot: StudyWHO Says Africa Will Get 30% of COVID Vaccines It Needs by FebruaryCOVID Vaccines for Kids Under 12 Could Come This Fall: FauciEbola Vaccine Effective in African Clinical TrialBritain OK's COVID Vaccine for Kids 12 and Older; Hopes to Avoid LockdownsIsraeli Data on COVID Boosters to Be Published This Week in Major Journal
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

New 'Mu' Coronavirus Variant Being Watched Closely: Fauci

HealthDay News
by Robert Preidt
Updated: Sep 3rd 2021

new article illustration

FRIDAY, Sept. 3, 2021 (HealthDay News) -- A new coronavirus variant called Mu that may be able to evade existing antibodies, including those from vaccines, is under close watch by U.S. health officials.

The variant hasn't taken extensive hold in the United States at this point, but the U.S. National Institute of Allergy and Infectious Diseases is taking it "very seriously," according to its director, Dr. Anthony Fauci, CBS News reported.

"We're keeping a very close eye on it... but it is not at all even close to being dominant," Fauci said. "As you know, the Delta is more than 99% dominant."

He noted that while Mu, technically known as B.1.621, has mutations suggesting "it would evade certain antibodies," there isn't a lot of clinical data to suggest that.

"It is mostly laboratory in vitro data," Fauci explained.

He added that officials "don't consider it an immediate threat right now," CBS News reported.

This week, the World Health Organization (WHO) designated Mu a "variant of interest," and said more research is needed to determine if it can evade existing antibodies.

Mu was first detected in Colombia in January.

Mu has been responsible for the country's third wave of coronavirus infections from April to June, Colombian health official Marcela Mercado told a local radio station on Thursday. She said there were nearly 700 deaths per day during that wave, and nearly two-thirds of tests from people who died came back positive for the Mu variant, CBS News reported.

In the past week, Colombia has seen just under 14,000 new cases of COVID-19 and 530 new deaths, according to Johns Hopkins University. Less than 30% of the country's citizens are fully vaccinated, CBS News reported.

"Although the global prevalence of the Mu variant among sequenced cases has declined and is currently below 0.1%, the prevalence in Colombia (39%) and Ecuador (13%) has consistently increased," according to the WHO, CBS News reported.

Some larger outbreaks of the Mu variant have been reported in South America and Europe.

Johns Hopkins University reported that Colombia has had about 14,000 new cases of COVID and 530 deaths this week, CBS reported. Its vaccination rate is below 30%.

More information

Find out more about COVID-19 variants at the U.S. Centers for Disease Control and Prevention.


SOURCE: CBS News